Pricing Log in Create free account

Eupraxia Pharmaceuticals Inc. (EPRX) vs Indaptus Therapeutics, Inc. (INDP)

Eupraxia Pharmaceuticals Inc. and Indaptus Therapeutics, Inc. are both Biotechnology companies. Eupraxia Pharmaceuticals Inc. and Indaptus Therapeutics, Inc. are of similar size ($446.2M and $437.7M). Across the 9 metrics below, Indaptus Therapeutics, Inc. leads on 5 and Eupraxia Pharmaceuticals Inc. on 4.

Valuation

Metric EPRX INDP Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 4.38 26.86 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (15.41%) (240.51%) (33.15%)
Free cash flow yield (8.72%) (4.81%) (25.50%)

Profitability

Metric EPRX INDP Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (117.82%) (318.04%) (56.36%)
Return on assets (64.44%) (163.84%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric EPRX INDP Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (35.53%) 52.15% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric EPRX INDP Biotechnology median
Debt to equity 0.01 0.00 0.00
Current ratio 16.00 19.48 4.72
Net debt to EBITDA 2.11 0.43 0.96

Dividend

Metric EPRX INDP Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric EPRX INDP Biotechnology median
Market cap 446.21m 437.70m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack